Our Vaccine appears safe for elderly in early trials: Chinese firm Sinovac Biotech

BEIJING, CHINA - SEPTEMBER 05: A booth displaying China's Sinovac Biotech Ltd. shows a COVID-19 vaccine candidate during the 2020 China International Fair for Trade in Services (CIFTIS) at Beijing Olympic Park on September 5, 2020 in Beijing, China. As China recovers from the COVID-19 epidemic, about 2,000 Chinese and foreign enterprises will participate and showcase their newest technology in public health and digital technology in the China International Fair for Trade in Services. (Photo by Lintao Zhang/Getty Images)

Vastavam web: Chinese firm Sinovac Biotech Ltd. said on Monday its coronavirus vaccine candidate appeared to be safe for older people, according to preliminary results. while the immune responses triggered by the vaccine were slightly weaker than for younger adults. They Said this vaccine did not cause severe side effects in combined Phase 1 and Phase 2 trials launched in May involving 421 participants aged at least 60, Liu Peicheng, Sinovac’s media representative, told.

The World Health Organization is working with China on requirements for international approval of any Chinese COVID-19 vaccine, a senior official said on Monday. “WHO’s office in China and WHO headquarters has been working with the regulatory authorities in China,” assistant director-general Mariangela Simao told a briefing in Geneva. “We are in direct contact. We have been sharing information and the requirements for international approval of vaccines.” Four of the world’s eight vaccines that are in the third phase of trials are from China.